Literature DB >> 8970009

Visual hallucinations in a geriatric psychiatry clinic: prevalence and associated diagnoses.

S Holroyd1.   

Abstract

Visual hallucinations are associated with a variety of psychiatric, medical, neurologic, and ophthalmologic disorders. One hundred forty outpatients presenting to a geriatric psychiatric clinic were screened for visual hallucinations and assessed on a number of descriptive variables, medical history, ophthalmologic history, psychiatric diagnosis, and cognitive score. The data revealed that 14 patients (10%) experienced visual hallucinations. Presence of visual hallucinations was significantly associated with diagnoses of dementia or delirium, living in a nursing home, lower cognitive score, and presence of auditory hallucinations and delusions. There was no association to number of medications, age, gender, or presence of eye disease. No patient had "insight' into their visual hallucinations. Despite the numerous disorders that are associated with visual hallucinations, the most common causes in a geriatric psychiatry clinic are dementia and delirium. Clinicians assessing older patients with visual hallucinations should first carefully evaluate for these disorders.

Entities:  

Mesh:

Year:  1996        PMID: 8970009     DOI: 10.1177/089198879600900403

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  4 in total

1.  Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops.

Authors:  R L Tomsak; C R Zaret; D Weidenthal
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Factors associated with drug-induced visual hallucinations in Parkinson's disease.

Authors:  Spiridon Papapetropoulos; Andreas A Argyriou; John Ellul
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

Review 3.  Visual hallucinations in Parkinson's disease: a review and phenomenological survey.

Authors:  J Barnes; A S David
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

4.  Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study.

Authors:  Daniel Ecker; Alexander Unrath; Jan Kassubek; Michael Sabolek
Journal:  BMC Neurol       Date:  2009-06-10       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.